BACKGROUND: Malaria control campaigns have reduced malaria transmission to very low levels in many areas of Africa. Yet the extent to which malaria interruption or elimination might decrease the prevalence of anemia in areas of low malaria transmission is unknown. METHODS: Kapsisiywa and Kipsamoite, highland areas of Kenya with low, unstable malaria transmission, experienced a 12-month interruption in malaria transmission from April 2007 to May 2008, following high-level coverage (>70% of households) with indoor residual insecticide spraying in 2007. Hemoglobin levels were tested in 1697 randomly selected asymptomatic residents of Kapsisiywa (n = 910) and Kipsamoite (n = 787) at the beginning of a 12-month period of interrupted transmission (in May 2007) and 14 months later (in July 2008). RESULTS: From May 2007 to July 2008, only 1 of 1697 study cohort members developed clinical malaria. In this period, the prevalence of anemia decreased in Kapsisiywa in all age groups (from 57.5% to 37.9% in children aged <5 years [P < .001], from 21.7% to 10.5% in children aged 5-14 years [P < .001], and from 22.7% to 16.6% in individuals aged ≥ 15 years [P = .004]). The prevalence of anemia in Kipsamoite also decreased in children aged <5 years (from 47.2% to 31.3%; P = .001) but was unchanged in children aged 5-14 years and in individuals aged ≥15 years. Among children <5 years, anemia prevalence was reduced by 34% in both Kapsisiywa (95% confidence interval [CI], 21%-45%) and Kipsamoite (95% CI, 16%-48%). CONCLUSIONS: Successful malaria elimination or interruption may lead to substantial reductions in anemia prevalence even in areas of very low transmission.
BACKGROUND:Malaria control campaigns have reduced malaria transmission to very low levels in many areas of Africa. Yet the extent to which malaria interruption or elimination might decrease the prevalence of anemia in areas of low malaria transmission is unknown. METHODS: Kapsisiywa and Kipsamoite, highland areas of Kenya with low, unstable malaria transmission, experienced a 12-month interruption in malaria transmission from April 2007 to May 2008, following high-level coverage (>70% of households) with indoor residual insecticide spraying in 2007. Hemoglobin levels were tested in 1697 randomly selected asymptomatic residents of Kapsisiywa (n = 910) and Kipsamoite (n = 787) at the beginning of a 12-month period of interrupted transmission (in May 2007) and 14 months later (in July 2008). RESULTS: From May 2007 to July 2008, only 1 of 1697 study cohort members developed clinical malaria. In this period, the prevalence of anemia decreased in Kapsisiywa in all age groups (from 57.5% to 37.9% in children aged <5 years [P < .001], from 21.7% to 10.5% in children aged 5-14 years [P < .001], and from 22.7% to 16.6% in individuals aged ≥ 15 years [P = .004]). The prevalence of anemia in Kipsamoite also decreased in children aged <5 years (from 47.2% to 31.3%; P = .001) but was unchanged in children aged 5-14 years and in individuals aged ≥15 years. Among children <5 years, anemia prevalence was reduced by 34% in both Kapsisiywa (95% confidence interval [CI], 21%-45%) and Kipsamoite (95% CI, 16%-48%). CONCLUSIONS: Successful malaria elimination or interruption may lead to substantial reductions in anemia prevalence even in areas of very low transmission.
Authors: Immo Kleinschmidt; Christopher Schwabe; Murugasampilay Shiva; Jose Luis Segura; Victor Sima; Samuel Jose Alves Mabunda; Michael Coleman Journal: Am J Trop Med Hyg Date: 2009-09 Impact factor: 2.345
Authors: David M Menge; Kacey C Ernst; John M Vulule; Peter A Zimmerman; Hongfei Guo; Chandy C John Journal: Am J Trop Med Hyg Date: 2008-08 Impact factor: 2.345
Authors: Karen I Barnes; David N Durrheim; Francesca Little; Amanda Jackson; Ushma Mehta; Elizabeth Allen; Sicelo S Dlamini; Joyce Tsoka; Barry Bredenkamp; D Jotham Mthembu; Nicholas J White; Brian L Sharp Journal: PLoS Med Date: 2005-10-04 Impact factor: 11.069
Authors: Chandy C John; Melissa A Riedesel; Ng'wena G Magak; Kim A Lindblade; David M Menge; James S Hodges; John M Vulule; Willis Akhwale Journal: Emerg Infect Dis Date: 2009-12 Impact factor: 6.883
Authors: Artemis Koukounari; Benson B A Estambale; J Kiambo Njagi; Bonnie Cundill; Anthony Ajanga; Christopher Crudder; Julius Otido; Matthew C H Jukes; Siân E Clarke; Simon Brooker Journal: Int J Parasitol Date: 2008-06-12 Impact factor: 3.981
Authors: Serign J Ceesay; Climent Casals-Pascual; Jamie Erskine; Samuel E Anya; Nancy O Duah; Anthony J C Fulford; Sanie S S Sesay; Ismaela Abubakar; Samuel Dunyo; Omar Sey; Ayo Palmer; Malang Fofana; Tumani Corrah; Kalifa A Bojang; Hilton C Whittle; Brian M Greenwood; David J Conway Journal: Lancet Date: 2008-11-01 Impact factor: 79.321
Authors: Achuyt Bhattarai; Abdullah S Ali; S Patrick Kachur; Andreas Mårtensson; Ali K Abbas; Rashid Khatib; Abdul-Wahiyd Al-Mafazy; Mahdi Ramsan; Guida Rotllant; Jan F Gerstenmaier; Fabrizio Molteni; Salim Abdulla; Scott M Montgomery; Akira Kaneko; Anders Björkman Journal: PLoS Med Date: 2007-11-06 Impact factor: 11.069
Authors: Anne E P Frosch; Bartholomew N Ondigo; George A Ayodo; John M Vulule; Chandy C John; Sarah E Cusick Journal: Am J Clin Nutr Date: 2014-07-30 Impact factor: 7.045
Authors: Cyrus Ayieko; Bilha S Ogola; Lyticia Ochola; Gideon A M Ngwena; George Ayodo; James S Hodges; Gregory S Noland; Chandy C John Journal: PeerJ Date: 2017-01-10 Impact factor: 2.984
Authors: Alinune N Kabaghe; Michael G Chipeta; Dianne J Terlouw; Robert S McCann; Michèle van Vugt; Martin P Grobusch; Willem Takken; Kamija S Phiri Journal: Am J Trop Med Hyg Date: 2017-08-18 Impact factor: 2.345
Authors: W Robert Taylor; Htee Khu Naw; Kathryn Maitland; Thomas N Williams; Melissa Kapulu; Umberto D'Alessandro; James A Berkley; Philip Bejon; Joseph Okebe; Jane Achan; Alfred Ngwa Amambua; Muna Affara; Davis Nwakanma; Jean-Pierre van Geertruyden; Muhindo Mavoko; Pascal Lutumba; Junior Matangila; Philipe Brasseur; Patrice Piola; Rindra Randremanana; Estrella Lasry; Caterina Fanello; Marie Onyamboko; Birgit Schramm; Zolia Yah; Joel Jones; Rick M Fairhurst; Mahamadou Diakite; Grace Malenga; Malcolm Molyneux; Claude Rwagacondo; Charles Obonyo; Endalamaw Gadisa; Abraham Aseffa; Mores Loolpapit; Marie-Claire Henry; Grant Dorsey; Chandy John; Sodiomon B Sirima; Karen I Barnes; Peter Kremsner; Nicholas P Day; Nicholas J White; Mavuto Mukaka Journal: BMC Med Date: 2018-01-18 Impact factor: 8.775